(Q43615052)

English

In vitro activity of pentavalent antimony derivatives on promastigotes and intracellular amastigotes of Leishmania infantum strains from humans and dogs in Spain

scientific article published in May 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

In vitro activity of pentavalent antimony derivatives on promastigotes and intracellular amastigotes of Leishmania infantum strains from humans and dogs in Spain (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

antimony(5+) cation

1 reference

based on heuristic

inferred from title

Leishmania infantum

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Montserrat Gállego

3

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

author name string

Carrió J

1

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Riera C

2

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Portús M

4

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 May 2001

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

79

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

179-183

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Leishmaniasis and AIDS co-infection: the Spanish example

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2801%2900125-5

7 January 2021

Drug cytotoxicity assay for African trypanosomes and Leishmania species

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2801%2900125-5

7 January 2021

An axenic amastigote system for drug screening

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2801%2900125-5

7 January 2021

Leishmania infantum: Stage-Specific Activity of Pentavalent Antimony Related with the Assay Conditions

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2801%2900125-5

7 January 2021

In vitro susceptibility of Leishmania infantum to meglumine antimoniate in isolates from repeated leishmaniasis episodes in HIV-coinfected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2801%2900125-5

7 January 2021

Stage-specific activity of pentavalent antimony against Leishmania donovani axenic amastigotes.

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2801%2900125-5

7 January 2021

Epidemiology of canine leishmaniosis in Catalonia (Spain) the example of the Priorat focus.

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2801%2900125-5

7 January 2021

Decreased sensitivity to meglumine antimoniate (Glucantime) ofLeishmania infantumisolated from dogs after several courses of drug treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2801%2900125-5

7 January 2021

Evidence that the High Incidence of Treatment Failures in Indian Kala‐Azar Is Due to the Emergence of Antimony‐Resistant Strains ofLeishmania donovani

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2801%2900125-5

7 January 2021

Prophylaxis of visceral leishmaniasis in human immunodeficiency virus-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2801%2900125-5

7 January 2021

Quantitative in vitro drug potency and drug susceptibility evaluation of Leishmania ssp. from patients unresponsive to pentavalent antimony therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2801%2900125-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0001-706X(01)00125-5

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43615052&oldid=2101907081"